ADN1.DEADN1.DEXETRA
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR-38.8%
5Y CAGR-9.7%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-38.8%/yr
vs +16.4%/yr prior
5Y CAGR
-9.7%/yr
Recent deceleration
Acceleration
-55.3pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.44 | -28.3% |
| 2023 | 0.62 | -28.1% |
| 2022 | 0.86 | -55.5% |
| 2021 | 1.93 | +68.4% |
| 2020 | 1.15 | +55.9% |
| 2019 | 0.73 | -9.9% |
| 2018 | 0.82 | -22.2% |
| 2017 | 1.05 | +1.4% |
| 2016 | 1.04 | +45.7% |
| 2015 | 0.71 | - |